ARCHIVES

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

BioSeek Awarded NIH SBIR For Compound Validation.

July 4, 2003

DCE Publishes Lister of Resources Available To Scientific Community

November 9, 1984

NCI Pilot to Speed Phase III Trials Deemed Unsuccessful, Will Be Shut Down

November 22, 2002

LAK –IL-2 Studies Continue, Moertel Editorial Blasted

March 13, 1987

DCT Moves Fast to Take Control Of Cooperative Groups, Get Multimodality Studies Under Way

October 3, 1975

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009